HNGE Latest Headlines

Evercore ISI Keeps Their Buy Rating on Hinge Health, Inc. Class A (HNGE)

at www.tipranks.com (Thu, 30-Apr 10:36 AM)

Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Teva Pharmaceutical (TEVA) and PROCEPT BioRobotics (PRCT)

at www.tipranks.com (Thu, 30-Apr 9:40 AM)

Hinge Health Buy Rating Reiterated on Growth Momentum and Migraine Expansion, Price Target Maintained at $72

at www.tipranks.com (Thu, 30-Apr 7:15 AM)

Hinge Health, Inc. Class A (HNGE) Receives a Buy from Canaccord Genuity

at www.tipranks.com (Thu, 30-Apr 7:05 AM)

Analyst Reiterates Buy on Hinge Health, Citing Near-Term Outperformance Potential and Long-Term Growth from New Migraine Care Program

at www.tipranks.com (Thu, 30-Apr 6:27 AM)

Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Ionis Pharmaceuticals (IONS) and GE Healthcare Technologies Inc (GEHC)

at www.tipranks.com (Thu, 30-Apr 5:03 AM)

Hinge Health Delivers Record 2025 Growth With Expanding Margins and Robust Client Metrics

Market Chameleon (Wed, 11-Feb 10:37 AM)

HNGE Delivers Record Results: Revenue Up 51%, Margins Climb, and Member Growth Accelerates

Market Chameleon (Wed, 11-Feb 7:37 AM)